TrialNeurology2026

Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Randomized Withdrawal Trial.

Roy Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.